Overview A Study of GSK1325760A in Healthy Japanese Subjects Status: Completed Trial end date: 2007-02-01 Target enrollment: Participant gender: Summary To investigate the safety, tolerability, pharmacokinetics and the effect of food on pharmacokinetics after single oral administrations of GSK1325760A Phase: Phase 1 Details Lead Sponsor: GlaxoSmithKline